Edwina J Wright
Head, Wright Group
Life Sciences
Burnet Institute
Australia
Biography
Currently Edwina chairs a large, international clinical trial designed to determine the impact of early antiretroviral treatment strategies upon HIV-associated neurocognitive performance. With regional colleagues she has studied the epidemiology of neurological disorders in the Asia-Pacific region. She is Chair of the Asia-Pacific NeuroAIDS Consortium (APNAC) and co-Chair of the Australasian National NeuroAIDS Brain and Tissue Bank Project.
Research Interest
With a strong interest in HIV-associated neurological disorders Edwina’s work in this area includes studies that address the pathogenesis of HIV infection of the brain and the benefits of different strategies to treat HIV brain infection.
Publications
-
Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system. Pierce AB, El-Hayek C, McCarthy D, Armishaw J, Watson K, Wilkinson A, Price B, Wright EJ, Hoy JF, Stoové MA Sex Health. 2017 Feb; 14(2):179-87
-
Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project. Lal L, Audsley J, Murphy D, Fairley CK, Stoove M, Roth N, Moore R, Tee BK, Puratmaja N, Anderson PL, Leslie D, Grant RM, De Wit J, Wright E; VicPrEP Study Team. AIDS. 2017 May; 31(12):1709-1714
-
Monitoring HIV-associated neurocognitive disorder using screenings: a critical review including guidelines for clinical and research use. Kamminga J, Lal L, Wright EJ, Bloch M, Brew BJ, Cysique LA Curr HIV/AIDS Rep. 2017 Jun; 14(3):83-92
